In the past 48 hours, President Trump has doubled down on plans to impose up to 25% tariffs on imported pharmaceuticals and APIs with a policy that threatens to worsen U.S. drug supply, drive up costs, and endanger patients.
Tariffs on healthcare related products have the worst impact on citizens. In a country like America where healthcare costs are already high, a tariff on imported medicines will make matters worse for everybody.
Here’s a detailed breakdown of what exactly would happen.
Immediate Price Increases
Even a modest tariff on imported medicines strains consumer budgets. The Association for Accessible Medicines, representing generic drug makers, reports Indian-made generics—which account for 90% of U.S. prescriptions, operate on narrow margins. Applying a 25% tariff would raise generics prices by 17.5% immediately, as noted by ING analysts
Cancer Treatments to be Costlier
Cancer patients are likely to bear the brunt of these tariffs. An analysis by ING shows that a 24-week generic chemotherapy regimen could cost patients $8,000–$10,000 under Trump’s proposed tariffs.
That kind of jump is not merely a policy hiccup but it’s a barrier to treatment. The costs increase by at least $2000 for the aforementioned chemotherapy regime.
Drug tariffs could raise the cost of some cancer treatments to $10,000 for a 24‑week course
–Derik Stadgig [Sector Economicst, Healthcare]
Insulin to be Costlier
Insulin, which millions of Americans rely on daily, is vulnerable to sudden price hikes if its components or formulations are subject to tariffs.
A modest increase of $10–$20 per vial could undo years of bipartisan efforts to cap insulin costs at $35/month. This affects not just uninsured users but those on employer health plans, who may already pay full retail prices depending on deductible structure
Drug Shortages cost $900M in Labour
And what more if Trump put tariffs on it? The clue is not difficult to crack, more wastage of time and wastage of taxpayer’s money!
A report by Vizient published just yesterday [17th of June,2025] elucidates that labour costs associated with drug shortages increased from $359M to $894M in just 5 years from 2019 to 2024. The time spent in managing these shortages also increased from 8.8 Million hours to 20.2 Million hours.
The impact ? Nurses and other healthcare associates are working harder and probably working longer hours to compensate for the drug shortages. It could also indicate that America is already in a drug shortage crisis, and Trump could worsen this permanently.
Market Value Wiped Away
Oliver Hail reports that Trump’s recent tariffs have wiped out the value of medical and pharmaceutical stocks, by as much as 3%. The effects are varied, but what about the investor’s perspective? We can safely estimate that millions of dollars have been wiped out in no time just yesterday, and to offset these losses, the working population could become targets of layoffs.
Insurance Premiums to Rise
Beyond the direct financial hit to consumers at the pharmacy counter, the anticipation of higher drug costs, even before tariffs are officially implemented, is already manifesting in rising health insurance premiums.
A critical report from the Kaiser Family Foundation (KFF), published June 17, 2025, reveals that several major health insurance carriers are explicitly raising their proposed 2026 premiums by more than they otherwise would, specifically citing the expectation that tariffs will drive up their prescription drug costs. This is a significant concern given that retail prescription drugs alone represent about 12% of all private health insurance spending.
Beyond the direct financial hit to consumers at the pharmacy counter, the anticipation of higher drug costs, even before tariffs are officially implemented, is already manifesting in rising health insurance premiums.
A critical report from the Kaiser Family Foundation (KFF), published just yesterday, June 17, 2025, reveals that several major health insurance carriers are explicitly raising their proposed 2026 premiums by more than they otherwise would, specifically citing the expectation that tariffs will drive up their prescription drug costs. This is a significant concern given that retail prescription drugs alone represent about 12% of all private health insurance spending.
For instance, UnitedHealthcare of Oregon is building a 2.20% price impact into its rate filing specifically due to tariff uncertainty.
Other prominent insurers, including Optimum Choice of Maryland, Independent Health Benefits Corporation of New York, and UnitedHealthcare of New York, are similarly raising premiums by an additional 2.4%, 2.9%, and 3.6% respectively, directly attributing these increases to the anticipated impact of tariffs on pharmaceuticals.
This, in our opinion, would be the largest loss to the American Citizen, because, Insurance companies don’t help with payouts anyways, therefore what’s the point of paying higher premiums?
Severe Drug Shortage Ahead
Let’s be honest, if these tariffs were implemented overnight, hospitals could hoard drugs or drug prices could rise immediately. People would start to hoard over-the-counter medicines, and these could disappear off the shelves in no time.
And, in a few days, costly drugs would appear on the new shelves! Some may be able to afford them, some may not.
Imposing tariffs on these vital imports does not magically create domestic manufacturing capacity overnight. Instead, it places immediate and severe financial strain on U.S. importers and manufacturers who are fundamentally reliant on these global inputs.
This can lead to immediate price increases, but also to delays in product availability, reduced orders from U.S. distributors, and even the unfortunate exit of foreign suppliers from the U.S. market. This concentration of supply among fewer remaining producers, or a reliance on new, unproven sources, inherently increases the risk of widespread and critical drug shortages.
Keep Drugs Affordable, Not Scarce
The statement justifies itself. Authorities like Trump may afford healthcare, but what about the common American? Trump’s healthcare is paid out of the taxpayer’s money, but what about the taxpayer himself. We hope Trump chickens out of this plan before it becomes a nightmare for everybody.
Also read
Trump’s BRICS Tariff: History Shows Retaliation Risks
Trump announces reciprocal tariffs for ‘fairness’ , US could lose existing markets
Trump hints at legislative proposal to secure borders and Raise Tariffs
Leave a Reply